Evaluating the Tolerability and Safety Profile of Switching from Rituximab to Ocrelizumab: A Real World Evaluation of Patients with Relapsing Forms of Multiple Sclerosis
This Study is
No Longer Enrolling
Adult
III/IV - A combination of phases: (3) Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants. and (4) Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.
Treatment
University of Colorado Hospital
Protocol Number: 16-1354
More information available at ClinicalTrials.gov: NCT02980042
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers